Myrobalan Therapeutics
PrivateLast Round
Grant
Mar 13, 2025
Total Funding Raised
$35.25M
Momentum Score
75 /100
Company Overview
Myrobalan Therapeutics is a biotechnology company focused on developing oral neurorestorative therapies designed to reverse the underlying pathologies of brain dysfunctions and central nervous system conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myrobalan Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Myrobalan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 13, 2025 | ||||
| Grant | Feb 7, 2024 | ||||
| Series A | Jan 10, 2024 | ||||
| Seed | Apr 1, 2022 |
Myrobalan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Co-Win Ventures | Series A |
| National MS Society | Grant |
| Ab Magnitude Ventures Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Partnered with University of Colorado Anschutz School of Medicine for preclinical research.
- Feb 23, 2026
Presented GPR17 antagonist research at ACTRIMS 2026 conference.
Myrobalan Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myrobalan Therapeutics's valuation, stock price, and market status.
